Kristen Millado

GU Oncologist and Benign Hematologist at Miami Cancer Institute @BaptistHealthSF

[Sharyn Foster @SharynMFoster]

This Group of experts from @miamicancerinst @KMilladoMD @BrunoBastosMD Antonio Muina & Maria Carla Dominguez got together @OncLiveSOSS to discuss metastatic RCC, UC #GUCancer & PARP Inhibitors in #prostatecancer. Superb presentations by all.

[Toni Choueiri, MD @DrChoueiri]

It is this time of the year again: TOP 20 GU Oncology clinical trials published in 2021:

Some negative, some positive, some led to @FDAOncology approval; we learned from all!

Feel free to add & retweet & tag anyone involved

This is not an exhaustive list

@OncoAlert

[ASCO @ASCO]

Dr. Timothy Kuzel, @KMilladoMD & @alantanmd answer the question, "Are HIF-2α inhibitors ready to be incorporated into the treatment of advanced clear cell #RCC?" https://t.co/HeV7fqZh0Z #ASCODailyNews #KCSM #GUCSM

[RUSH Heme/Onc @RushHemOnc]

Meet Kristen — one of our amazing chief fellows and outdoors enthusiast! Her fun loving personality makes every day in the office exciting! @KMilladoMD @RushCancer @RushHemOnc

[Kristen Millado @KMilladoMD]

@Cancer_talks Well deserved. Congratulations!!

[Kristen Millado @KMilladoMD]

Successful #SABCS19! A wonderful opportunity to learn from so many experts in this field. A special thank you to all my mentors at RUMC. @RushCancer

[Kristen Millado @KMilladoMD]

Great seeing you @DailyDoseMD and hearing about all your great work at the FDA! #SABCS19

[Danielle Krol, MD @DanielleKrolMD]

Lovely time chatting with my former #GW colleague @KristenMillado at #SABCS19 who is doing great things as a Heme/ONC Fellow at Rush now! So proud of her #meded

[Priya Rajakumar @PRajakumarMD]

Rush representing at #ASH2019! @RushCancer